Sonorous Neurovascular Achieves First Canadian Enrollment in B-SILENT Study, Expanding Global Momentum

LAKE FOREST, Calif., Aug. 3, 2026 /PRNewswire/ -- Sonorous Neurovascular, a pioneering medical device company focused on innovative solutions for cerebral venous diseases and neurovascular interventions, today announced a significant clinical milestone: the first patient enrollment in...